Mov Disord Vol 38, Suppl 1 Archives - Page 125 of 186 - MDS Abstracts

2023 International Congress
Deep brain stimulation modulates subthalamic beta bursts related to movement velocity adjustments in Parkinson’s disease
M. Bange, G. Gonzalez-Escamilla, DM. Herz, G. Tinkhauser, M. Glaser, D. Ciolac, H. Tan, P. Brown, S. Groppa (Mainz, Germany)
Objective: The aim of this study was to investigate the role of subthalamic beta bursts for dynamic control of precise drawing movements. Background: The performance…
2023 International Congress
Slow progressive neurocognitive impairment with Parkinsonism: A rare, adult-onset Neuronal Intranuclear Inclusion disease (NIID) case report
AS. Mawardi, AA. Ab Ghapar, NH. Rahim, J. Joseph (Kuala Lumpur, Malaysia)
Objective: We described a case of a 62-years old lady with underlying diabetes and hypertension, presented with right upper intermittent resting tremor and stiffness for…
2023 International Congress
Unsupervised multimodal digital assessment of fatigue and sleep disorders in Parkinson’s disease: the IDEA-FAST study
A. Pilotto, J. Kudelka, L. Correia, E. Lirani-Silva, J. Jimenez Ramos, S. Labrecque, R. Romijnders, C. Hansen, C. Maetzler, A. Rizzardi, C. Zatti, U. Funken, W. Remmele, A. Santos, S. Del Din, L. Rochester, J. Ferreira, A. Padovani, A. Yarnall, K. Seppi, F. Ng, W. Maetzler (Brescia, Italy)
Objective: To evaluate fatigue and sleep disorders in unsupervised conditions in neurodegenerative and autoimmune conditions using a combination of mobility, autonomic and sleep digital home…
2023 International Congress
Stepwise Dual-Target MR-guided Focused Ultrasound in A Patient with Advanced Parkinson’s Disease
CH. Tsai, MK. Lu, JC. Chen, CM. Chen (Taichung, Taiwan)
Objective: To illustrate a successful stepwise dual target MRI guided focused ultrasound ablation in a patient with advanced Parkinson's disease (PD). Background: MR-guided focused ultrasound…
2023 International Congress
Improvement in motor symptoms and quality of life in patients with an earlier stage of advanced Parkinson’s disease treated with foslevodopa/foscarbidopa subcutaneous 24 hour infusion
A. Antonini, B. Bergmans, D. Kern, P. Odin, L. Bergmann, R. Gupta, J. Homola, M. Shah, J. Zamudio, D. Standaert (Padova, Italy)
Objective: To evaluate whether treatment with foslevodopa/foscarbidopa (LDP/CDP), a continuous (24‑hour/day) subcutaneous infusion of carbidopa/levodopa prodrugs, improves motor fluctuations and quality of life (QoL) in…
2023 International Congress
Parkinson’s Disease Hospital Optimization Project
B. Valdovinos, K. Amodeo, E. Kanouse, A. Chesire, J. Lowell, M. Braun, N. Chunga, D. Ruebeck, A. Macikowski, V. Basic, M. Deweese, E. Hufziger, J. Hayes, A. Skuse, I. Richard (Rochester, USA)
Objective: To describe The Parkinson’s Disease Hospital Optimization Project (PD-HOP) that we established to optimize inpatient care and improve the hospital experience and outcomes for…
2023 International Congress
Clinico-pathological correlations in atypical parkinsonism
R. Fumi, M. Theilmann Jensen, L. Wu, D. Vaughan, V. Chelban, Y. Goh, R. Real, A. Martinez Carrasco, E. Jabbari, A. Church, J. Coebergh, C. Kobylecki, U. Nath, M. Hu, A. Misbahuddin, J. Sharma, L. Massey, E. Capps, A. Robinson, F. Roncaroli, A. Lees, O. Ansorge, K. Allison, T. Warner, J. Rohrer, T. Revesz, Z. Jaunmuktane, J. Rowe, H. Houlden, H. Morris (London, United Kingdom)
Objective: We aim to assess diagnostic accuracy of the Parkinson-plus syndromes (PPS) using the current consensus criteria, whilst identifying the diagnostically most salient clinical features.…
2023 International Congress
Anodal Transcranial Direct Current Stimulation (tDCS) on sensorimotor cortex in patients with early-onset Parkinson’s Disease: a Pilot Study.
C. Simonetta, J. Bissacco, M. Conti, V. Ferrari, M. Pierantozzi, C. Salimei, A. Stefani, NB. Mercuri, T. Schirinzi (Roma, Italy)
Objective: To evaluate the clinical effects of anodal Transcranial Direct Current Stimulation (tDCS) application on sensorimotor cortex in a group of early-onset Parkinson’s Disease patients.…
2023 International Congress
Effect and Mechanism of Shaoyao Gancao Decoction(SGD) in Treatment of Pain in Parkinson’s Disease Based on Network Pharmacology and Molecular Docking
Q. Zhao (Shanghai, China)
Objective: Based on the method of network pharmacology, this paper discusses the potential effects and mechanisms of SGD in the treatment of pain in PD. Background:…
2023 International Congress
Differences by sex in patients with Parkinson’s disease (PD) and impulse control disorder (ICD) in the Mexican population.
A. Alcocer-Salas, M. Rodriguez-Violante, A. Cervantes-Arriaga, J. García-Hernández, A. Abundes-Corona, A. Hernández-Medrano, D. Aguila-Godinez, A. Herrera-Ruiz, E. Santiago-Delacruz, L. Lira-Juárez, M. Medrano-Delgado, M. Ruiz-Mafud, A. Regalado-Mustafá, D. Romero-Terán, M. Medina-Pérez, G. Hernandez-Armesto, A. Domínguez-García (Merida, Mexico)
Objective: To identify motor, cognitive and overall ICDs differences by sex in Mexican patients with PD and ICDs Background: ICDs are characterized by a failure…